Advertisement
Canada markets close in 22 minutes

  • S&P/TSX

    21,828.94
    +100.39 (+0.46%)
     

  • S&P 500

    5,060.46
    +42.07 (+0.84%)
     

  • DOW

    38,186.84
    +283.55 (+0.75%)
     

  • CAD/USD

    0.7313
    +0.0031 (+0.43%)
     

  • CRUDE OIL

    79.07
    +0.07 (+0.09%)
     

  • Bitcoin CAD

    80,800.27
    +2,518.97 (+3.22%)
     

  • CMC Crypto 200

    1,274.74
    +4.00 (+0.31%)
     

  • GOLD FUTURES

    2,314.20
    +3.20 (+0.14%)
     

  • RUSSELL 2000

    2,016.27
    +36.04 (+1.82%)
     

  • 10-Yr Bond

    4.5710
    -0.0240 (-0.52%)
     

  • NASDAQ

    15,826.15
    +220.67 (+1.41%)
     

  • VOLATILITY

    14.80
    -0.59 (-3.83%)
     

  • FTSE

    8,172.15
    +50.91 (+0.63%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • CAD/EUR

    0.6815
    +0.0022 (+0.32%)
     
MARKETS LIVE BLOG:

STOCKS SURGE AS RATE-HIKE FEARS FADE, WITH APPLE ON DECK

Paramount shares jump on Sony, Apollo US$26 billion buyout offer: Report

A Closer Look At Bristol-Myers Squibb Company's (NYSE:BMY) Impressive ROE

editorial-team@simplywallst.com (Simply Wall St)
·3 min read

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. By way of learning-by-doing, we'll look at ROE to gain a better understanding of Bristol-Myers Squibb Company (NYSE:BMY).

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

View our latest analysis for Bristol-Myers Squibb

How Do You Calculate Return On Equity?

The formula for ROE is:

ADVERTISEMENT

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

So, based on the above formula, the ROE for Bristol-Myers Squibb is:

27% = US$8.0b ÷ US$29b (Based on the trailing twelve months to December 2023).

The 'return' is the amount earned after tax over the last twelve months. So, this means that for every $1 of its shareholder's investments, the company generates a profit of $0.27.

Does Bristol-Myers Squibb Have A Good ROE?

Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. The limitation of this approach is that some companies are quite different from others, even within the same industry classification. As is clear from the image below, Bristol-Myers Squibb has a better ROE than the average (19%) in the Pharmaceuticals industry.

roe
roe

That is a good sign. Bear in mind, a high ROE doesn't always mean superior financial performance. A higher proportion of debt in a company's capital structure may also result in a high ROE, where the high debt levels could be a huge risk .

How Does Debt Impact Return On Equity?

Most companies need money -- from somewhere -- to grow their profits. The cash for investment can come from prior year profits (retained earnings), issuing new shares, or borrowing. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the debt used for growth will improve returns, but won't affect the total equity. In this manner the use of debt will boost ROE, even though the core economics of the business stay the same.

Combining Bristol-Myers Squibb's Debt And Its 27% Return On Equity

Bristol-Myers Squibb does use a high amount of debt to increase returns. It has a debt to equity ratio of 1.35. Its ROE is pretty impressive but, it would have probably been lower without the use of debt. Debt does bring extra risk, so it's only really worthwhile when a company generates some decent returns from it.

Conclusion

Return on equity is one way we can compare its business quality of different companies. Companies that can achieve high returns on equity without too much debt are generally of good quality. All else being equal, a higher ROE is better.

Having said that, while ROE is a useful indicator of business quality, you'll have to look at a whole range of factors to determine the right price to buy a stock. Profit growth rates, versus the expectations reflected in the price of the stock, are a particularly important to consider. So you might want to take a peek at this data-rich interactive graph of forecasts for the company.

But note: Bristol-Myers Squibb may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.